In this context, we think that co-immunostaining experiments with MMP-9 and ERR beta, would not have allowed us to consider that we have specifically discriminated the cholinergic modulation from that of fast MNs to slow MNs throughout ALS pathogenesis. This evidence concerns the gene MMP9 and amyotrophic lateral sclerosis.